Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Progress in Molecular Biology and Translational Science
|
June 27, 2021
Genome editing in lysosomal disorders
Luisa Natalia Pimentel-Vera, Edina Poletto, Esteban Alberto Gonzalez, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
September 20, 2023
Characterization of heart disease in mucopolysaccharidosis type II mice
Angela Maria Vicente Tavares, Esteban Alberto Gonzalez, Isabelle Souza Viana, et al.
Archives of Oral Biology
|
December 6, 2023
Comparison of different DNA preservation solutions for oral cytological samples
Júlia Silveira Nunes, Luisa Natalia Pimentel-Vera, Sabrina Barcelos Silva, et al.
Metabolic Brain Disease
|
August 27, 2022
Evaluation of oxidative stress and mitochondrial function in a type II mucopolysaccharidosis cellular model: in vitro effects of genistein and coenzyme Q10
Carlos Eduardo Diaz Jacques, Franciele Fátima Lopes, Edina Poletto, et al.
Cell Biochemistry and Function
|
February 9, 2024
Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model
Camila Aguilar Delgado, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Current Gene Therapy
|
May 5, 2021
In Situ Gene Therapy
Hallana Souza Santos, Luiza Rodrigues, Luisa Natalia Pimentel Vera, et al.
Pharmaceutics
|
March 28, 2026
Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I
Hallana Souza Santos, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Gene Therapy
|
December 13, 2019
Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice
Roselena Silvestri Schuh, Esteban Alberto Gonzalez, Angela Maria Vicente Tavares, et al.
Nature Communications
|
July 5, 2024
CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice
Pasqualina Colella, Ruhi Sayana, Maria Valentina Suarez-Nieto, et al.
The Journal of Gene Medicine
|
January 15, 2022
Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system
Luisa Natalia Pimentel Vera, Roselena Silvestri Schuh, Flavia Nathielly Silveira Fachel, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Progress in Molecular Biology and Translational Science
|
June 27, 2021
Genome editing in lysosomal disorders
Luisa Natalia Pimentel-Vera, Edina Poletto, Esteban Alberto Gonzalez, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
September 20, 2023
Characterization of heart disease in mucopolysaccharidosis type II mice
Angela Maria Vicente Tavares, Esteban Alberto Gonzalez, Isabelle Souza Viana, et al.
Archives of Oral Biology
|
December 6, 2023
Comparison of different DNA preservation solutions for oral cytological samples
Júlia Silveira Nunes, Luisa Natalia Pimentel-Vera, Sabrina Barcelos Silva, et al.
Metabolic Brain Disease
|
August 27, 2022
Evaluation of oxidative stress and mitochondrial function in a type II mucopolysaccharidosis cellular model: in vitro effects of genistein and coenzyme Q10
Carlos Eduardo Diaz Jacques, Franciele Fátima Lopes, Edina Poletto, et al.
Cell Biochemistry and Function
|
February 9, 2024
Effect of genistein and coenzyme Q10 in oxidative damage and mitochondrial membrane potential in an attenuated type II mucopolysaccharidosis cellular model
Camila Aguilar Delgado, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Current Gene Therapy
|
May 5, 2021
In Situ Gene Therapy
Hallana Souza Santos, Luiza Rodrigues, Luisa Natalia Pimentel Vera, et al.
Pharmaceutics
|
March 28, 2026
Liposomal CRISPR/Cas9-Mediated Local Genome Editing for Joint Disease in Mucopolysaccharidosis Type I
Hallana Souza Santos, Edina Poletto, Luisa Natalia Pimentel Vera, et al.
Gene Therapy
|
December 13, 2019
Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice
Roselena Silvestri Schuh, Esteban Alberto Gonzalez, Angela Maria Vicente Tavares, et al.
Nature Communications
|
July 5, 2024
CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice
Pasqualina Colella, Ruhi Sayana, Maria Valentina Suarez-Nieto, et al.
The Journal of Gene Medicine
|
January 15, 2022
Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system
Luisa Natalia Pimentel Vera, Roselena Silvestri Schuh, Flavia Nathielly Silveira Fachel, et al.
Page
of 2